Federica Miglietta, Medical Oncologist, Researcher at Department of Surgery, Oncology and Gastroenterology at University of Padova, shared a post on LinkedIn:
“Pleased to share our new study in ESMO Open on CNS and leptomeningeal involvement in advanced breast cancer.
In ER+/HER2- disease, ILC was associated with a higher risk of leptomeningeal involvement and a poorer prognosis once it occurred, compared with NST breast cancer.
Grateful to all my co-authors and to the University of Padua for supporting this research through the STARS UNIPD grant.”
Title: Patterns of central nervous system and leptomeningeal involvement in advanced breast cancer with invasive lobular histology: a large multicenter study with a focus on estrogen receptor-positive/HER2-negative disease
Authors: F. Miglietta, C. Vernieri, T. Giarratano, G. Griguolo, M. Bottosso, A. Vingiani, F. Piacentini, M. Cacciatore, A. Botticelli, G. Fotia, P. Napolitano, G. Landa, G.M. Vernaci, E. Di Liso, L. Casadei, D. Palleschi, G. Pruneri, A.P. Dei Tos, V. Guarneri, M.V. Dieci
Read the Full Article on ESMO Open
You can also read: ESMO 2026 Metastatic Breast Cancer Guideline: Biomarker-Driven Therapy Reshapes Treatment Across Subtypes
